| Gene symbol | MUC1 | Synonyms | ADMCKD, ADMCKD1, ADTKD2, CA 15-3, CD227, Ca15-3, EMA, H23AG, KL-6, MAM6, MCD, MCKD, MCKD1, MUC-1, MUC-1/SEC, MUC-1/X, MUC1/ZD, PEM, PEMT, PUM | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1q22 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | mucin 1, cell surface associated | ||||
| GTO ID | GTC0814 |
| Trial ID | ChiCTR1900025088 |
| Disease | Breast Cancer |
| Altered gene | MUC1 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | AJMUC1 |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | Clinical study for CAR-T cells in the treatment of MUC1 - positive advanced breast cancer |
| Year | 2019 |
| Country | China |
| Company sponsor | Sun Yat-sen Memorial Hospital, Sun Yat-sen University |
| Cohort 1 | |||||||
|
|||||||